Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morus alba leaf capsule extract for nephropathic complications in type 2 diabetes mellitus
IRCT2016021512438N18Phase 2Completed
- Sponsor
- Barij Essence
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mulberry leaf extract in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Barij Essence. Started Apr 2016; status: completed.
02
Drugs
mulberry leaf extract
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT2016021512438N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016021512438N18.